Rajeev Raghuvanshi appointed head of apex drug regulatory panel

Current Secretary-cum-Scientific Director at Indian Pharmacopoeia Commission, has been given the DCGI charge for a three-year period ending on February 28, 2025

An official statement on February 22, 2023 stated that the Appointments Committee of the Cabinet has approved the appointment of Rajeev Raghuvanshi as the new Drug Controller General of India (DCGI).


The appointment has been made in “Level 14 of the Pay Matrix”, on “short term” contract basis, and with effect from the “date of his assumption of charge of the post till his attaining the age of superannuation on 28.02.2025, or until further orders, whichever is earlier”, the release stated.

Raghuvanshi’s appointment was recommended for the top post by the Union Public Service Commission (UPSC), which had conducted an interview of the probable candidates and assessed their profile.

UPSC had communicated to the Union health ministry last month, “The Commission on the basis of assessment of bio-data of the eligible officers received…and after holding personal talks with them on January 27 recommend Dr Rajeev Singh Raghuvanshi for appointment to the post of Drug Controller (India) by short term contract basis,”